High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study

por Malucchi, Simona, Capobianco, Marco, Lo Re, Marianna, Malentacchi, Maria, di Sapio, Alessia, Matta, Manuela, Sperli, Francesca, Bertolotto, Antonio
Publicado 2016

Tailoring Rituximab According to CD27-Positive B-Cell versus CD19-Positive B-Cell Monitoring in Neuromyelitis Optica Spectrum Disorder and MOG-Associated Disease: Results from a Si...

por Bruschi, Nicolò, Malentacchi, Maria, Malucchi, Simona, Sperli, Francesca, Martire, Serena, Sala, Arianna, Valentino, Paola, Bertolotto, Antonio, Pautasso, Marisa, Capobianco, Marco Alfonso
Publicado 2023

Vitamin D Binding Protein Isoforms and Apolipoprotein E in Cerebrospinal Fluid as Prognostic Biomarkers of Multiple Sclerosis

por Perga, Simona, Giuliano Albo, Alessandra, Lis, Katarzyna, Minari, Nicoletta, Falvo, Sara, Marnetto, Fabiana, Caldano, Marzia, Reviglione, Raffaella, Berchialla, Paola, Capobianco, Marco A., Malentacchi, Maria, Corpillo, Davide, Bertolotto, Antonio
Publicado 2015